Nanog inhibits the switch of myogenic cells towards the osteogenic lineage

Bose S Kochupurakkal1, Rachel Sarig, Ora Fuchs

  • 1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.

Insights

The homeodomain transcription factor Nanog controls pluripotency in embryonic stem cells. Nanog inhibits trans-differentiation of committed cells, not terminal differentiation, by blocking new gene transcription.

Area of Science:

  • Stem cell biology
  • Developmental biology
  • Molecular genetics

Background:

  • The homeodomain transcription factor Nanog is crucial for maintaining pluripotency in embryonic stem (ES) cells.
  • Nanog's role in differentiation and lineage commitment requires further elucidation.

Purpose of the Study:

  • To investigate the specific roles of Nanog in cellular differentiation and lineage plasticity.
  • To determine if Nanog inhibits terminal differentiation or trans-differentiation in committed cells.

Main Methods:

  • Ectopic expression of Nanog in mouse myogenic C2 cells.
  • Assessment of terminal muscle differentiation.
  • Induction of osteogenic differentiation using BMP treatment.
  • Gene expression profiling and analysis of key differentiation markers (e.g., ERK 1/2 phosphorylation, alkaline phosphatase, osteocalcin).

Main Results:

  • Nanog expression did not affect terminal muscle differentiation in C2 cells.
  • Nanog significantly inhibited the osteogenic trans-differentiation of C2 cells upon BMP stimulation.
  • Key osteogenic markers and signaling pathways (ERK 1/2) showed suppressed induction in Nanog-expressing cells.

Conclusions:

  • Nanog acts as an inhibitor of trans-differentiation in committed cells.
  • This inhibition is dependent on the de novo activation of gene transcription.
  • Nanog's function is context-dependent, affecting lineage plasticity rather than terminal differentiation potential.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...